Rejuvenating Neurons and Glia with Microbial Enzymes

  • Aubrey D. N. J. de Grey

All the major neurodegenerative diseases are characterised by the accumulation of proteinaceous aggregates within neurons. The commonest of such conditions, Alzheimer’s disease, also features extracellular proteinaceous aggregates (amyloid). The role of these aggregates in the aetiology and progression of cognitive impairment is still unclear, but their absence in young adults suggests that their removal would at any rate not be harmful.


Nerve Growth Factor Natural Rubber Senile Plaque Progressive Supranuclear Palsy Microbial Enzyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brooks, D.A., Kakavanos, R. and Hopwood, J.J., 2003, Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder. Trends Mol. Med. 9: 450.CrossRefPubMedGoogle Scholar
  2. Cuervo, A.M., 2004, Autophagy: in sickness and in health. Trends Cell Biol. 14: 70.CrossRefPubMedGoogle Scholar
  3. de Grey, A.D.N.J., 2002, Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome. Trends Biotechnol. 20: 452.CrossRefPubMedGoogle Scholar
  4. de Grey, A.D.N.J., Alvarez, P.J.J., Brady, R.O., Cuervo, A.M., Jerome, W.G., McCarty, P.L., Nixon, R.A., Rittmann, B.E. and Sparrow, J.R., 2005, Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Res. Rev. 4: 315.CrossRefPubMedGoogle Scholar
  5. De Rosa, R., Garcia, A.A., Braschi, C., Capsoni, S., Maffei, L., Berardi, N. and Cattaneo, A., 2005, Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl Acad. Sci. USA 102: 3811.CrossRefPubMedGoogle Scholar
  6. Francis, J.C. and Hansche, P.E., 1972, Directed evolution of metabolic pathways in microbial populations. I. Modification of the acid phosphatase pH optimum in S. cerevisiae. Genetics 70: 59.Google Scholar
  7. Gayle, E.F., 1952, The Chemical Activities of Bacteria. Academic Press, London.Google Scholar
  8. Ghosh, P., Dahms, N.M. and Kornfeld, S., 2003, Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 4: 202.CrossRefPubMedGoogle Scholar
  9. Hoffner, G., Kahlem, P. and Djian, P., 2002, Perinuclear localization of Huntington as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington’s disease. J. Cell Sci. 115: 941.PubMedGoogle Scholar
  10. Lewis, T.A., Newcombe, D.A. and Crawford, R.L., 2004, Bioremediation of soils contaminated with explosives. J. Environ. Manage 70: 291.CrossRefPubMedGoogle Scholar
  11. Ma, Q.L., Lim, G.P., Harris-White, M.E., Yang, F., Ambegaokar, S.S., Ubeda, O.J., Glabe, C.G., Teter, B., Frautschy, S.A. and Cole, G.M., 2006, Antibodies against beta-amyloid reduce abeta oligomers, glycogen synthase kinase-3-beta activation and tau phosphorylation in vivo and in vitro. J. Neurosci. Res. 83: 374.CrossRefPubMedGoogle Scholar
  12. Pardridge, W.M., 2002, Drug and gene delivery to the brain: the vascular route. Neuron 36: 555.CrossRefPubMedGoogle Scholar
  13. Paresce, D.M., Chung, H. and Maxfield, F.R., 1997, Slow degradation of aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272: 29390.CrossRefPubMedGoogle Scholar
  14. Rose, K. and Steinbuchel, A., 2005, Biodegradation of natural rubber and related compounds: recent insights into a hardly understood catabolic capability of microorganisms. Appl. Environ. Microbiol. 71: 2803.CrossRefPubMedGoogle Scholar
  15. Roses, A.D., 1994, Apolipoprotein E affects the rate of Alzheimer’s disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53: 429.CrossRefPubMedGoogle Scholar
  16. Ross, C.A., Wood, J.D., Schilling, G., Peters, M.F., Nucifora, F.C., Cooper, J.K., Sharp, A.H., Margolis, R.L. and Borchelt, D.R., 1999, Polyglutamine pathogenesis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354: 1005.CrossRefPubMedGoogle Scholar
  17. Schenk, D., 2002, Amyloid-β immunotherapy for Alzheimer’s disease: the end of the beginning. Nat. Rev. Neurosci. 3: 824.CrossRefPubMedGoogle Scholar
  18. Schenk, D., 2004, Hopes remain for an Alzheimer’s vaccine. Nature 431: 398.CrossRefPubMedGoogle Scholar
  19. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D. and Seubert, P., 1999, Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400: 173.CrossRefPubMedGoogle Scholar
  20. Schiffmann, R. and Brady, R.O., 2002, New prospects for the treatment of lysosomal storage diseases. Drugs 62: 733.CrossRefPubMedGoogle Scholar
  21. Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., Sang, H., Bakay, R., Patel, P., Blesch, A., Vahlsing, H.L., Ho, G., Tong, G., Potkin, S.G., Fallon, J., Hansen, L., Mufson, E.J., Kordower, J.H., Gall, C. and Conner, J., 2005, A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer’s disease. Nat. Med. 11: 551.CrossRefPubMedGoogle Scholar
  22. Warhurst, A.M. and Fewson, C.A., 1994, Biotransformations catalyzed by the genus Rhodococcus. Crit. Rev. Biotechnol. 14: 29.CrossRefPubMedGoogle Scholar
  23. Wittich, R.M., 1998, Degradation of dioxin-like compounds by microorganisms. Appl. Microbiol. Biotechnol. 49: 489.CrossRefPubMedGoogle Scholar
  24. Wittlin, S., Rosel, J., Hofmann, F. and Stover, D.R., 1999, Mechanisms and kinetics of procathepsin D activation, Eur. J. Biochem. 265: 384.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Aubrey D. N. J. de Grey
    • 1
  1. 1.Department of GeneticsUniversity of CambridgeUK

Personalised recommendations